The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AVEO; Bayer; Genentech; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bayer; Novartis; Pfizer
S-TRAC trial: Sensitivity analyses of disease-free survival (DFS).
 
Daniel J. George
Honoraria - Bayer; BIOPHARM; Dendreon; Medivation; Novartis; Sanofi
Consulting or Advisory Role - Acceleron Pharma; Astellas Pharma; Bayer; Bristol-Myers Squibb; Celgene; Dendreon; Exelixis; Genentech; GlaxoSmithKline; Innocrin Pharma; Janssen; Medivation; Merck Sharp & Dohme; Myovant Sciences; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Dendreon; Novartis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer; Exelixis; Genentech/Roche; Medivation; Merck; Pfizer
 
Allan J. Pantuck
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
 
Alain Ravaud
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Bernard Escudier
No Relationships to Disclose
 
Michael D. Staehler
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Ipsen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Novartis; Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
 
Lucile Serfass
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Sriram Krishnaswami
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Michelle Casey
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Mariajose Lechuga
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Gary Koch
Consulting or Advisory Role - Pfizer (Inst)
 
Robert A. Figlin
Consulting or Advisory Role - Acceleron Pharma; Calithera Biosciences; Nektar; Novartis; Peloton Therapeutics; Pfizer
Research Funding - Argos Therapeutics; Bristol-Myers Squibb; Cerulean Pharma; Exelixis; Peloton Therapeutics